Titan Pharmaceuticals
TTNP
#10774
Rank
โ‚ฌ5.37 M
Marketcap
4,04ย โ‚ฌ
Share price
-3.76%
Change (1 day)
19.82%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -4,00ย โ‚ฌ

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -3,85ย โ‚ฌ. In 2023 the company made an earnings per share (EPS) of -6,49ย โ‚ฌ an increase over its 2022 EPS that were of -13,30ย โ‚ฌ.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-4,00ย โ‚ฌ
2023-6,49ย โ‚ฌ-51.22%
2022-13,30ย โ‚ฌ-15.61%
2021-15,77ย โ‚ฌ-81.37%
2020-84,61ย โ‚ฌ-77.52%
2019-376,46ย โ‚ฌ-56.32%
2018-861,89ย โ‚ฌ-59.51%
2017-2.129ย โ‚ฌ-371.81%
2016783,22ย โ‚ฌ-144.35%
2015-1.766ย โ‚ฌ300%
2014-441,46ย โ‚ฌ-121.54%
20132.050ย โ‚ฌ-151.38%
2012-3.989ย โ‚ฌ-11.54%
2011-4.509ย โ‚ฌ188.89%
2010-1.561ย โ‚ฌ-10%
2009-1.734ย โ‚ฌ
2007-7.111ย โ‚ฌ-2.38%
2006-7.284ย โ‚ฌ-39.13%
2005-11.967ย โ‚ฌ-16.87%
2004-14.395ย โ‚ฌ-22.43%
2003-18.557ย โ‚ฌ4.9%
2002-17.690ย โ‚ฌ61.9%
2001-10.926ย โ‚ฌ-13.7%
2000-12.660ย โ‚ฌ71.51%
1999-7.382ย โ‚ฌ-35.87%
1998-11.511ย โ‚ฌ-1824.71%
1997667,42ย โ‚ฌ-102.4%
1996-27.865ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
7,65ย โ‚ฌ-299.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
6,15ย โ‚ฌ-259.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-1,24ย โ‚ฌ-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
0,81ย โ‚ฌ-120.96%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-0,22ย โ‚ฌ-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-3,41ย โ‚ฌ-11.39%๐Ÿ‡บ๐Ÿ‡ธ USA